載入市場數據中...
2026年8月26日星期三
LineVest LogoLineVest

LineVest

新聞

美國市場與金融最新消息

新聞
Korea's NPS Faces KRW 20–74 Trillion Rebalancing Sell-Off as KOSPI Hits 8,476
新聞

Korea's NPS Faces KRW 20–74 Trillion Rebalancing Sell-Off as KOSPI Hits 8,476

Korea's NPS faces mandatory equity rebalancing of KRW 20–74 trillion starting July 1, as the KOSPI rally near 8,476 has pushed the pension fund's domestic equity ratio to ~30%, above its 28.8% upper band.

2026.06.30.0
Wemade Founder Sells KRW 920 Billion Stake to China-Linked NeoPulse, Handing Mir IP Control to Alibaba-Tied Investor
新聞

Wemade Founder Sells KRW 920 Billion Stake to China-Linked NeoPulse, Handing Mir IP Control to Alibaba-Tied Investor

Wemade (112040.KS) founder Park Kwan-ho is selling his entire 39.33% stake to China-linked NeoPulse for KRW 920B (USD 593M), with the Hong Kong-registered Shengsong Investment affiliate set to become the largest shareholder at 40.25% by October 30, 2026.

2026.06.30.0
Samsung SDI and SK On Gain Edge as Korea Mega-Project Plans Embed KRW 3.4 Trillion in Battery Demand
新聞

Samsung SDI and SK On Gain Edge as Korea Mega-Project Plans Embed KRW 3.4 Trillion in Battery Demand

Samsung SDI and SK On are positioned to capture the bulk of Korea KRW 3.4-4.3 trillion ESS and data-center battery pipeline embedded in the mega-project blueprint, while LG Energy Solution faces capacity constraints.

2026.06.30.0
Korea's Battery Trio Moves Fastest to Claw Back US Tariff Cash as Hyundai Stays on the Sidelines
新聞

Korea's Battery Trio Moves Fastest to Claw Back US Tariff Cash as Hyundai Stays on the Sidelines

LG Energy Solution leads Korea's battery makers in reclaiming over KRW 100B from US tariff refunds after Supreme Court ruling, while Hyundai Motor stays cautious amid Trump retaliation threats.

2026.06.30.0
KakaoBank FinTech Lab Lands Four Papers at ICLR, ACL and LREC, Staking Out Korea's Bank-Side AI Safety Frontier
新聞

KakaoBank FinTech Lab Lands Four Papers at ICLR, ACL and LREC, Staking Out Korea's Bank-Side AI Safety Frontier

KakaoBank's FinTech Research Institute had four financial AI safety papers accepted at ICLR 2026, ACL (with KAIST), and LREC — covering prompt injection defense and a financial-risk AI safety taxonomy.

2026.06.30.0
Samsung Electronics Union Chief Survives Confidence Vote With 87.5% Mandate, Eyes Separate DS Chip Bargaining in 2027
新聞

Samsung Electronics Union Chief Survives Confidence Vote With 87.5% Mandate, Eyes Separate DS Chip Bargaining in 2027

Samsung Electronics' largest union reconfirms chair Choi Seung-ho with 87.5% approval (33,550/38,336 votes), plans to push for DS division as separate bargaining unit in 2027 wage talks.

2026.06.30.0
L&F Signs Pre-IPO Stake in CIS Chemical as Korea's Battery Makers Race to Internalize Critical Mineral Recycling
新聞

L&F Signs Pre-IPO Stake in CIS Chemical as Korea's Battery Makers Race to Internalize Critical Mineral Recycling

L&F (066970.KQ) has inked a pre-IPO strategic investment in CIS Chemical, a Korean battery mineral recycling specialist with 20,000 t/year NiCo MHP capacity and proprietary SSX lithium recovery technology, targeting KOSDAQ Q3 2026.

2026.06.30.2
LG Chem Clears FDA Hurdle for LG00313112, a Novel Covalent TP53 Inhibitor for Rare Solid Tumors
新聞

LG Chem Clears FDA Hurdle for LG00313112, a Novel Covalent TP53 Inhibitor for Rare Solid Tumors

LG Chem (051910.KS) won U.S. FDA IND clearance for LG00313112, a first-in-class covalent TP53 Y220C inhibitor licensed from Frontier Medicines, targeting ovarian, lung, and breast cancers in Phase 1/2 trials.

2026.06.30.0
US Consumers File 'Chipflation' Antitrust Suit Against Samsung, SK Hynix and Micron in California Federal Court
新聞

US Consumers File 'Chipflation' Antitrust Suit Against Samsung, SK Hynix and Micron in California Federal Court

US consumers and small businesses have filed a class action antitrust suit against Samsung, SK Hynix and Micron, alleging the DRAM oligopoly coordinated supply cuts — hiding behind the HBM pivot — to drive a 700% price surge in standard memory.

2026.06.30.1
SK Bioscience Q1 2026: CDMO Revenue Surges as IDT Biologika Ramps Up, R&D Spend Triples Operating Loss
新聞

SK Bioscience Q1 2026: CDMO Revenue Surges as IDT Biologika Ramps Up, R&D Spend Triples Operating Loss

SK Bioscience (302440.KS) Q1 2026: Revenue KRW 168.6B (+9.1% YoY), CDMO 75.8% of mix. Operating loss KRW -44.5B triples as R&D hits 35.4% of revenue. IDT Biologika utilization improves to 59.4%.

2026.06.30.3
Samsung's Chip Division Caught Off Guard by Honam Fab Plan, Insiders Warn of Logistics Gaps and Cycle Risk
新聞

Samsung's Chip Division Caught Off Guard by Honam Fab Plan, Insiders Warn of Logistics Gaps and Cycle Risk

Samsung DS working-level executives were reportedly blindsided by President Lee's KRW 800 trillion Honam fab announcement. Insiders flag Yongin already stalled 7 months, logistics inefficiency, engineer shortage, and memory cycle timing risk as key concerns.

2026.06.29.0
Foreign Investors Post All-Time KRX Net Sell Record of KRW 7.7 Trillion in Samsung, SK Hynix
新聞

Foreign Investors Post All-Time KRX Net Sell Record of KRW 7.7 Trillion in Samsung, SK Hynix

Foreign investors offloaded a record KRW 7.7 trillion of Samsung Electronics and SK Hynix on June 29, while KOSPI closed just -0.2% as capital rotated into LG Energy Solution, Samsung SDI, and infrastructure stocks.

2026.06.29.0